A kind of medicament of treating periodontitis
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament of treating periodontitis.
Background technology
Periodontitis is a chronic inflammatory disease of invading gingiva and periodontal tissue, is a kind of destructive disease, and its principal character is the formation of periodontal pocket and the inflammation of bag wall, and frontal resorption and tooth are loosening gradually, and it is the main cause that causes adult's loss of tooth.Many because the bacterial plaque of primary disease, tartar, food impaction, bad dummy is stung wound etc. and is caused that various focusing depths represented swelling makes bacterial plaque pile up simultaneously and increases the weight of, and is expanded down by gingivally on the gum and to prolong.Because microecological environment under the gum is growing a large amount of bigger periodontal pathogenic bacterium of virulence, like the gingiva bacteroid in the subgingival plaque; Intermediate bacillus, spirillums etc. increase the weight of the inflammation of gingiva and expand and prolong; Cause periodontal pocket to form and frontal resorption, cause periodontitis.
Summary of the invention
The purpose of this invention is to provide a kind of medicament of treating periodontitis.
In order to realize the object of the invention; The present invention provides a kind of medicament of treating periodontitis, and it is to be processed by weight by following bulk drugs: Herba Taxilli 3-10 part, Myrrha 10-20 part, Radix Astragali 10-30 part, Herba Hedyotidis Diffusae 10-30 part, Olibanum 5-15 part, Flos Lonicerae 5-10 part, Herba Asari 5-15 part, Herba Plantaginis 10-20 part, Radix Angelicae Dahuricae 10-20 part and Pericarpium Citri Reticulatae 10-20 part.
Preferably, it is to be processed by weight by following bulk drugs: 15 parts of 5 parts of Herba Taxillis, 15 parts of Myrrhas, 20 parts of the Radixs Astragali, 20 parts of Herba Hedyotidis Diffusae, 10 parts of Olibanums, 5 parts of Flos Loniceraes, 10 parts of Herba Asaris, 15 parts of Herba Plantaginiss, 15 parts of the Radixs Angelicae Dahuricae and Pericarpium Citri Reticulataes.
Preferably, said medicament is tablet, dispersible tablet, instant, powder or collutory.
The medicament of treatment periodontitis of the present invention uses natural drug, have effect rapidly, therapeutic effect obviously, better tolerance, advantage with low cost, without any side effects.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 collutory of the present invention
Get Herba Taxilli 50 grams, Myrrha 150 grams, the Radix Astragali 200 grams, Herba Hedyotidis Diffusae 200 grams, Olibanum 100 grams, Flos Lonicerae 50 grams, Herba Asari 100 grams, Herba Plantaginis 150 grams, the Radix Angelicae Dahuricae 150 grams and Pericarpium Citri Reticulatae 150 grams; Place in the flask of sealing; Add 800 gram water, heating is 5 hours under 70 ℃ water-bath, filters; Collect filtrating, sterilizing promptly gets.
Experimental example
Diagnostic criteria with reference to the relevant criterion of " clinic diagnosis guide stomatology fascicle " that Chinese Medical Association formulates carry out (Chinese Medical Association. clinic diagnosis guide stomatology fascicle. Beijing: People's Health Publisher, 2004; 25-26.).That is: 1. the degree of depth>3mm is examined in spy, and attachment loss>1mm is arranged.2. it is visible hemorrhage that the back is examined in visible redness of periodontal pocket surface gingiva or spy.3. X-ray film prompting phatnoma bone height reduces.
Choose the 50 routine patients that meet above-mentioned standard, male 25 examples, women 25 examples; 19 years old-49 years old age.
Use the collutory of embodiment 1 preparation to treat, use 30ml to gargle at every turn.Every day 3 times.Used for 1 week continuously.
Criterion of therapeutical effect
Produce effects: the disappearance of swelling and ache of gingival hemorrhage pyorrhea, odontoseisis alleviates, depth of pocket decline 2mm, GI drop by half, gingival hemorrhage index are 0; Take a turn for the better: the alleviation of swelling and ache of gingival hemorrhage pyorrhea, odontoseisis alleviates, and depth of pocket decline 1mm, gingival hemorrhage index are 1; Invalid: the gingival hemorrhage pyorrhea symptom that swells and ache is not seen obvious improvement, and odontoseisis does not have and alleviates, and depth of pocket does not have decline.
The result
In totally 50 routine patients, all meet the criterion of therapeutical effect of produce effects.
Untoward reaction
In therapeutic process, carry out tracing observation for 50 routine patients, do not find tangible untoward reaction.